Tapewire

Nasdaq · USD

OPCH

Option Care Health, Inc.

Export transactions ↓
Tapewire entity
4126
SEC CIK
0001014739
Parsed reports
380

Last 12 months

Inside the activity.

5 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202640
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 06, 2026 Filed Jul 8, 2026 20:26 UTC
Bhatia PrateekEVP Sp Sales & Solutions
GrantCommon Stock 23,409 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-023044 · rdgdoc.xml · nonDerivative · entry 2

Bhatia Prateek · CIK 0002143504 · EVP Sp Sales & Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,795

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
July 06, 2026 Filed Jul 8, 2026 20:26 UTC
Bhatia PrateekEVP Sp Sales & Solutions
GrantCommon Stock 16,386 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-023044 · rdgdoc.xml · nonDerivative · entry 1

Bhatia Prateek · CIK 0002143504 · EVP Sp Sales & Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,386

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:08 UTC GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018303 · rdgdoc.xml · nonDerivative · entry 1

Bierbower Elizabeth D · CIK 0001561149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,871

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:08 UTC GrantCommon Stock 844 $22.23 $18,762.12
Disclosure

SEC source: 0001437749-26-018302 · rdgdoc.xml · nonDerivative · entry 2

Deckmann Natasha · CIK 0001902330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,002

F2 · shares: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:08 UTC GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018302 · rdgdoc.xml · nonDerivative · entry 1

Deckmann Natasha · CIK 0001902330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,158

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:07 UTC GrantCommon Stock 12,079 $22.23 $268,516.17
Disclosure

SEC source: 0001437749-26-018301 · rdgdoc.xml · nonDerivative · entry 2

KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 471,076

F2 · shares: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:07 UTC GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018301 · rdgdoc.xml · nonDerivative · entry 1

KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,997

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:07 UTC GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018300 · rdgdoc.xml · nonDerivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,620

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:06 UTC GrantCommon Stock 4,836 $22.23 $107,504.28
Disclosure

SEC source: 0001437749-26-018299 · rdgdoc.xml · nonDerivative · entry 2

SULLIVAN TIMOTHY P · CIK 0001245970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,216

F2 · shares: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:06 UTC GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018299 · rdgdoc.xml · nonDerivative · entry 1

SULLIVAN TIMOTHY P · CIK 0001245970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,380

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:06 UTC GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018298 · rdgdoc.xml · nonDerivative · entry 1

Bodem Barbara W. · CIK 0001713893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,087

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:05 UTC GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018297 · rdgdoc.xml · nonDerivative · entry 1

Wright Norman L. · CIK 0001933103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,498

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:05 UTC
BRANDT ERICDirector
GrantCommon Stock 2,643 $22.23 $58,753.89
Disclosure

SEC source: 0001437749-26-018296 · rdgdoc.xml · nonDerivative · entry 2

BRANDT ERIC · CIK 0001190639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,999

F2 · shares: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 20, 2026 Filed May 22, 2026 22:05 UTC
BRANDT ERICDirector
GrantCommon Stock 8,997 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018296 · rdgdoc.xml · nonDerivative · entry 1

BRANDT ERIC · CIK 0001190639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,356

F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:08 UTC
Smyser CollinGC & Corporate Secretary
Exercise / conversionRestricted Stock Unit · Derivative 812 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018065 · rdgdoc.xml · derivative · entry 4

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 812 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F2 · derivative.exercise_date: All restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date.

F2 · derivative.expiration_date: All restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:08 UTC
Smyser CollinGC & Corporate Secretary
Tax withholdingCommon Stock 360 $20.86 $7,509.60
Disclosure

SEC source: 0001437749-26-018065 · rdgdoc.xml · nonDerivative · entry 2

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,012

Read SEC document
May 19, 2026 Filed May 21, 2026 20:08 UTC
Smyser CollinGC & Corporate Secretary
Exercise / conversionCommon Stock 812 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018065 · rdgdoc.xml · nonDerivative · entry 1

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,372

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2026 Filed May 7, 2026 21:04 UTC PurchaseCommon Stock 24,154 $20.69 $499,671.38
Disclosure

SEC source: 0001437749-26-015657 · rdgdoc.xml · nonDerivative · entry 1

SULLIVAN TIMOTHY P · CIK 0001245970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,383

F1 · price: Reflects the weighted average price of 24,154 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 7, 2026 with purchase prices ranging from $20.47 to $20.69 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
May 04, 2026 Filed May 4, 2026 21:42 UTC
Sethna MeenalChief Financial Officer
PurchaseCommon Stock 16,225 $20.16 $327,074.91
Disclosure

SEC source: 0001437749-26-014693 · rdgdoc.xml · nonDerivative · entry 1

Sethna Meenal · CIK 0001643464 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,337

F1 · price: Reflects the weighted average price of 16,225 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 4, 2026 with purchase prices ranging from $19.94 to $20.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
May 04, 2026 Filed May 4, 2026 21:41 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
PurchaseCommon Stock 12,500 $21.18 $264,706.25
Disclosure

SEC source: 0001437749-26-014692 · rdgdoc.xml · nonDerivative · entry 1

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 695,152

F1 · price: Reflects the weighted average price of 12,500 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 4, 2026 with purchase prices ranging from $21.14 to $21.18 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
May 04, 2026 Filed May 5, 2026 21:32 UTC PurchaseCommon Stock 36,610 $21.41 $783,772.51
Disclosure

SEC source: 0001437749-26-014959 · rdgdoc.xml · nonDerivative · entry 1

KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

F1 · price: Reflects the weighted average price of 36,610 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 4, 2026 with purchase prices ranging from $21.35 to $21.475 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:40 UTC
Adewunmi FemiChief Medical Officer
Tax withholdingCommon Stock 1,396 $28.38 $39,618.48
Disclosure

SEC source: 0001437749-26-013334 · rdgdoc.xml · nonDerivative · entry 1

Adewunmi Femi · CIK 0002020079 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,314

Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:54 UTC SaleCommon Stock 30,287 $32.05 $970,619.60
Disclosure

SEC source: 0001437749-26-006650 · rdgdoc.xml · nonDerivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,623

F1 · price: Reflects the weighted average price of 30,287 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on February 27, 2026 with sale prices ranging from $32.00 to $32.275 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:53 UTC
Bavaro MichaelChief Human Resources Officer
SaleCommon Stock 6,000 $33.00 $198,000.00
Disclosure

SEC source: 0001437749-26-006649 · rdgdoc.xml · nonDerivative · entry 1

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,249

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:53 UTC
Whitworth LukeChief Operating Officer
Tax withholdingCommon Stock 4,605 $33.82 $155,718.08
Disclosure

SEC source: 0001437749-26-005927 · rdgdoc.xml · nonDerivative · entry 1

Whitworth Luke · CIK 0001961976 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,589

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:53 UTC
Grashoff Christopher L.Chief Growth Officer
Tax withholdingCommon Stock 1,980 $33.82 $66,953.70
Disclosure

SEC source: 0001437749-26-005926 · rdgdoc.xml · nonDerivative · entry 1

Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,092

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:52 UTC
Smyser CollinGC & Corporate Secretary
Tax withholdingCommon Stock 2,210 $33.82 $74,731.15
Disclosure

SEC source: 0001437749-26-005925 · rdgdoc.xml · nonDerivative · entry 1

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,560

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:49 UTC
Adewunmi FemiChief Medical Officer
Tax withholdingCommon Stock 1,627 $33.82 $55,017.01
Disclosure

SEC source: 0001437749-26-005923 · rdgdoc.xml · nonDerivative · entry 1

Adewunmi Femi · CIK 0002020079 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,710

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:48 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
Tax withholdingCommon Stock 11,050 $33.82 $373,655.75
Disclosure

SEC source: 0001437749-26-005920 · rdgdoc.xml · nonDerivative · entry 1

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 682,652

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:47 UTC
Bavaro MichaelChief Human Resources Officer
Tax withholdingCommon Stock 1,354 $33.82 $45,785.51
Disclosure

SEC source: 0001437749-26-005919 · rdgdoc.xml · nonDerivative · entry 1

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,249

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:46 UTC
Maggio NicoleChief Accounting Officer
Tax withholdingCommon Stock 975 $33.82 $32,969.63
Disclosure

SEC source: 0001437749-26-005918 · rdgdoc.xml · nonDerivative · entry 1

Maggio Nicole · CIK 0002032392 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,489

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:20 UTC
Bavaro MichaelChief Human Resources Officer
Tax withholdingCommon Stock 12,212 $35.69 $435,846.28
Disclosure

SEC source: 0001437749-26-005419 · rdgdoc.xml · nonDerivative · entry 2

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,603

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:19 UTC
Grashoff Christopher L.Chief Growth Officer
Tax withholdingCommon Stock 538 $35.69 $19,201.22
Disclosure

SEC source: 0001437749-26-005416 · rdgdoc.xml · nonDerivative · entry 2

Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,072

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:18 UTC
Maggio NicoleChief Accounting Officer
Tax withholdingCommon Stock 372 $35.69 $13,276.68
Disclosure

SEC source: 0001437749-26-005414 · rdgdoc.xml · nonDerivative · entry 2

Maggio Nicole · CIK 0002032392 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,464

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:17 UTC
Whitworth LukeChief Operating Officer
Tax withholdingCommon Stock 24,029 $35.69 $857,595.01
Disclosure

SEC source: 0001437749-26-005411 · rdgdoc.xml · nonDerivative · entry 2

Whitworth Luke · CIK 0001961976 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,194

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:16 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
Tax withholdingCommon Stock 132,848 $35.69 $4,741,345.12
Disclosure

SEC source: 0001437749-26-005408 · rdgdoc.xml · nonDerivative · entry 4

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 693,702

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:15 UTC
Smyser CollinGC & Corporate Secretary
Tax withholdingCommon Stock 15,433 $35.69 $550,803.77
Disclosure

SEC source: 0001437749-26-005406 · rdgdoc.xml · nonDerivative · entry 2

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,770

Read SEC document
February 21, 2026 Filed Feb 25, 2026 00:16 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Unit · Derivative 11,087 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-005408 · rdgdoc.xml · derivative · entry 5

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,087 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F2 · derivative.exercise_date: Fully vested

F2 · derivative.expiration_date: Fully vested

Read SEC document
February 21, 2026 Filed Feb 25, 2026 00:16 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
Tax withholdingCommon Stock 4,956 $35.69 $176,879.64
Disclosure

SEC source: 0001437749-26-005408 · rdgdoc.xml · nonDerivative · entry 3

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 826,550

Read SEC document
February 21, 2026 Filed Feb 25, 2026 00:16 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 11,087 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-005408 · rdgdoc.xml · nonDerivative · entry 2

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 831,506

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:20 UTC
Bavaro MichaelChief Human Resources Officer
Tax withholdingCommon Stock 1,187 $35.69 $42,364.03
Disclosure

SEC source: 0001437749-26-005419 · rdgdoc.xml · nonDerivative · entry 1

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,815

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:19 UTC
Grashoff Christopher L.Chief Growth Officer
Tax withholdingCommon Stock 1,948 $35.69 $69,524.12
Disclosure

SEC source: 0001437749-26-005416 · rdgdoc.xml · nonDerivative · entry 1

Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,610

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:18 UTC
Maggio NicoleChief Accounting Officer
Tax withholdingCommon Stock 619 $35.69 $22,092.11
Disclosure

SEC source: 0001437749-26-005414 · rdgdoc.xml · nonDerivative · entry 1

Maggio Nicole · CIK 0002032392 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,836

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:17 UTC
Whitworth LukeChief Operating Officer
Tax withholdingCommon Stock 4,015 $35.69 $143,295.35
Disclosure

SEC source: 0001437749-26-005411 · rdgdoc.xml · nonDerivative · entry 1

Whitworth Luke · CIK 0001961976 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,223

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:16 UTC
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
Tax withholdingCommon Stock 10,638 $35.69 $379,670.22
Disclosure

SEC source: 0001437749-26-005408 · rdgdoc.xml · nonDerivative · entry 1

RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 820,419

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:15 UTC
Smyser CollinGC & Corporate Secretary
Tax withholdingCommon Stock 2,012 $35.69 $71,808.28
Disclosure

SEC source: 0001437749-26-005406 · rdgdoc.xml · nonDerivative · entry 1

Smyser Collin · CIK 0001924779 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,203

Read SEC document
February 18, 2026 Filed Feb 20, 2026 01:02 UTC
Whitworth LukeChief Operating Officer
GrantCommon Stock 30,423 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004781 · rdgdoc.xml · nonDerivative · entry 2

Whitworth Luke · CIK 0001961976 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,238

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 01:02 UTC
Grashoff Christopher L.Chief Growth Officer
GrantCommon Stock 12,678 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004780 · rdgdoc.xml · nonDerivative · entry 2

Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,558

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 01:01 UTC
Bavaro MichaelChief Human Resources Officer
GrantCommon Stock 9,579 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004779 · rdgdoc.xml · nonDerivative · entry 2

Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,002

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 01:00 UTC
Maggio NicoleChief Accounting Officer
GrantCommon Stock 4,226 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-004778 · rdgdoc.xml · nonDerivative · entry 2

Maggio Nicole · CIK 0002032392 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,455

F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.